Your browser doesn't support javascript.
loading
Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome.
Takemoto, Tomoya; Baba, Masayuki; Yokoyama, Kazumasa; Kitagawa, Kohei; Nagayasu, Kazuki; Ago, Yukio; Seiriki, Kaoru; Hayata-Takano, Atsuko; Kasai, Atsushi; Mori, Daisuke; Ozaki, Norio; Takuma, Kazuhiro; Hashimoto, Ryota; Hashimoto, Hitoshi; Nakazawa, Takanobu.
Affiliation
  • Takemoto T; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Baba M; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Yokoyama K; Discovery Accelerator, Astellas Pharma Inc., Tsukuba-shi, Ibaraki, 305-8585, Japan.
  • Kitagawa K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Nagayasu K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Ago Y; Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Seiriki K; Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, 734-8553, Japan.
  • Hayata-Takano A; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Kasai A; Interdisciplinary Program for Biomedical Sciences, Institute for Transdisciplinary Graduate Degree Programs, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Mori D; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Ozaki N; United Graduate School of Child Development, Molecular Research Center for Children's Mental Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, 565-0871, Japan.
  • Takuma K; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Hashimoto R; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
  • Hashimoto H; Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, 466-8550, Japan.
  • Nakazawa T; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
Mol Brain ; 15(1): 26, 2022 03 28.
Article de En | MEDLINE | ID: mdl-35346312
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Comportement social / Ocytocine / Délétion de segment de chromosome / Trouble du spectre autistique / Déficience intellectuelle Aspects: Determinantes_sociais_saude Limites: Animals Langue: En Journal: Mol Brain Sujet du journal: BIOLOGIA MOLECULAR / CEREBRO Année: 2022 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Comportement social / Ocytocine / Délétion de segment de chromosome / Trouble du spectre autistique / Déficience intellectuelle Aspects: Determinantes_sociais_saude Limites: Animals Langue: En Journal: Mol Brain Sujet du journal: BIOLOGIA MOLECULAR / CEREBRO Année: 2022 Type de document: Article Pays d'affiliation: Japon